Skip to Content

'
George H. Perkins, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1993 University of North Carolina School of Medicine, Chapel Hill, NC, MD, Highest Honors, Medicine
1988 University of North Carolina School of Medicine, Chapel Hill, NC, Public Health Degree, with Distinction, Public Health
1985 Wake Forest University, Winston - Salem, NC, BS, Medical Sciences

Postgraduate Training

1/1999-1/2000 Fellowship in Outcomes Research, Fellowship in Breast Radiation Oncology, The University Of Texas, M. D. Anderson Cancer Center, Houston, TX, Luka Milas, MD Howard Thames, PhD, Program Directo
1/1995-1/1999 Residency, Radiation Oncology, The University Of Texas, M. D. Anderson Cancer Center, Houston, TX, Patricia J. Eifel, MD, Program Director
1/1994-1/1995 Internship, Mayo Clinic and Graduate School of Medicine, Jacksonville, FL, Rochester, MN., Mayo Clinic and Graduate School of Medicine, Rochester, MN, Gary M Lee, MD
6/1993-6/1994 Post-Doctoral Research Fellowship Award, Lineberger Comprehensive Cancer Center Fellowship in Cancer Cell Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, Stephen Haskill, PhD and Joel Tepper, MD - Directors

Board Certifications

5/1999 The American Board of Radiology

Honors and Awards

2008 Top Doctor, Castly Connolly Medical Ltd.
2007-2008 Best Doctors in America, Best Doctors, Incorporated
2007 America's Top Radiologists (Radiation Oncology), Consumer Research Council of America
2007 Outstanding Health Professionals Worldwide, International Centre, Cambridge, England
2005-2006 Best Doctors In America, Best Doctors, Incorporated
2005 Luis Delclos Excellence in Teaching Award, The University of Texas M. D. Anderson Cancer Center
1999 Chairman, Quality of Education Committee (Chief Resident), The University of Texas M. D. Anderson Cancer Center
1999 National Research Service Award, The University of Texas M. D. Anderson Cancer Center
1996 Berlex Oncology Foundation Award
1995 American Medical Association/Glaxo Wellcome Residency Achievement Award, American Medical Association/Glaxo Wellcome
1993 Christopher C. Fordham III Leadership Award, Univ. of North Carolina, School of Medicine
1993 Lineberger Comprehensive Cancer Center Award, Univ. of North Carolina, School of Medicine
1992 Medical Foundation Board of Directors Merit Award, Univ. of North Carolina, School of Medicine
1991 Distinguished Medical Scholars Award, Univ. of North Carolina, School of Medicine
1990 Warwick Fellowship Award, Univ. of North Carolina School of Medicine, Great Britain National Public Health Service
1989 William B.D. MacNider Award, Univ. of North Carolina, School of Medicine
1988 Chancellor’s Scholar Award, Univ. of North Carolina, School of Medicine
1988 Delta Omega Honor Society Award, Univ. of North Carolina, School of Public Health

Selected Publications

Peer-Reviewed Original Research Articles
1. Smith GL, Shih YC, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA. Radial disparities in the use of radiotherapy after breast-conserving surgery: A national Medicare study. Cancer 116(3):734-41, 2/1/2010. e-Pub 1/2010. PMID: 20014181.
2. Zhang YJ, Oh JL, Whitman GJ, Iyengar P, Yu TK, Tereffe W, Woodward WA, Perkins G, Buchholz TA, Strom EA. Clinically apparent internal mammary nodal metastasis in patients with advance breast cancer: Incidence and local control. Int J Radiat Oncol Biol Phys. e-Pub 1/2010. PMID: 20004535.
3. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg 209(4):425-433.e2, 10/2009. e-Pub 8/20/2009. PMID: 19801315.
4. Reed VK, Woodward WA, Zhang L, Strom EA, Perkins GH, Tereffe W, Oh JL, Yu TK, Bedrosian I, Whitman GJ, Buchholz TA, Dong L. Automatic Segmentation of Whole Breast Using Atlas Approach and Deformable Image Registration. Int J Radiat Oncol Biol Phys 73(5):1493-500, 4/1/2009. e-Pub 9/17/2008. PMCID: PMC2729433.
5. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, Perkins GH, Elting LS. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a two-year follow-up study. J Clin Oncol 27(12):2007-2014, 4/20/2009. e-Pub 3/16/2009. PMID: 19289624.
6. Ludwig MS, McNeese MD, Buchholz TA, Perkins GH, Strom EA. The lateral decubitus breast boost: description, rationale and efficacy. Int J Radiat Oncol Biol Phys 76(1). e-Pub 4/2009. PMID: 19394161.
7. Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA. Ten-Year Recurrence Rates in Young Women With Breast Cancer by Locoregional Treatment Approach. Int J Radiat Oncol Biol Phys 73(3):734-44, 3/1/2009. e-Pub 8/15/2008. PMID: 18707822.
8. Beadle BM, Woodward WA, Middleton LP, Tereffe W, Strom EA, Litton JK, Meric-Bernstam F, Theriault RL, Buchholz TA, Perkins GH. The impact of pregnancy on breast cancer outcomes in women
9. Garg AK, Frija EK, Sun TL, Strom EA, Perkins GH, Oh JL, Yu TK, Woodward WA, Tereffe WA, Salehpour M, Buchholz TA. Effects of Variable Placement of Superior Tangential/Supraclavicular Match Line on Dosimetric Coverage of Level III Axilla/Axillary Apex in Patients Treated with Breast and Supraclavicular Radiotherapy. Int J Radiat Oncol Biol Phys 73(2):370-4, 2/1/2009. PMID: 18676090.
10. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: State of the Science and Roadmap to Advance the Field. J Clin Oncol 27(2):279-88, 1/10/2009. e-Pub 12/8/2008. PMID: 19064970.
11. Mathew J, Perkins GH, Stephens T, Middleton LP, Yang WT. Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. AJR Am J Roentgenol 191(6):1631-9, 12/2008. PMID: 19020230.
12. Gadre SA, Perkins GH, Sahin AA, Sneige N, Deavers MT, Middleton LP. Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion. Histopathology 53(5):545-53, 11/2008. PMID: 18983463.
13. Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA. Locoregional Treatment Outcomes After Multimodality Management Of Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 72(2):474-84, 10/1/2008. e-Pub 4/24/2008. PMID: 18439768.
14. De Giorgi U, Perkins GH, Cristofanilli M. Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual? J Clin Oncol 26(24):4044-7, 8/20/2008. PMID: 18711199.
15. Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SH. Radiation Use and Long-Term Survival in Breast Cancer Patients with T1, T2 Primary Tumors and One to Three Positive Axillary Lymph Nodes. Int J Radiat Oncol Biol Phys 71(4):1022-7, 7/15/2008. e-Pub 1/30/2008. PMID: 18234447.
16. Reed VK, Cavalcanti JL, Strom EA, Perkins GH, Oh JL, Tereffe W, Yu TK, Yeung H, Whitman GJ, Bedrosian I, Macapinlac HA, Buchholz TA, Woodward WA. Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer. Int J Radiat Oncol Biol Phys 71(2):435-40, 6/1/2008. e-Pub 12/31/2007. PMID: 18164831.
17. Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-9, 3/15/2008. PMID: 18213620.
18. Woodward WA, Durand JB, Tucker SL, Strom EA, Perkins GH, Oh J, Arriaga L, Domain D, Buchholz TA. Prospective analysis of carotid artery flow in breast cancer patients treated with supraclavicular irradiation 8 or more years previously: no increase in ipsilateral carotid stenosis after radiation noted. Cancer 112(2):268-73, 1/15/2008. PMID: 18000801.
19. Garg AK, Oh JL, Oswald MJ, Huang E, Strom EA, Perkins GH, Woodward WA, Yu TK, Tereffe W, Meric-Bernstam F, Hahn K, Buchholz TA. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicin-based neoadjuvant chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys 69(5):1478-83, 12/1/2007. e-Pub 9/12/2007. PMID: 17855016.
20. Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TA. Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer 110(11):2420-7, 12/1/2007. PMID: 17941034.
21. Liengsawangwong R, Yu TK, Sun TL, Erasmus JJ, Perkins GH, Tereffe W, Oh JL, Woodward WA, Strom EA, Salephour M, Buchholz TA. Treatment optimization using computed tomography-delineated targets should be used for supraclavicular irradiation for breast cancer. Int J Radiat Oncol Biol Phys 69(3):711-5, 11/1/2007. PMID: 17889264.
22. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 10/2007. PMID: 17826073.
23. Middleton LP, Perkins GH, Tucker SL, Sahin AA, Singletary SE. Expression of ERalpha and ERbeta in lobular carcinoma in situ. Histopathology 50(7):875-80, 6/2007. PMID: 17543077.
24. Borghero YO, Salehpour M, McNeese MD, Stovall M, Smith SA, Johnson J, Perkins GH, Strom EA, Oh JL, Kirsner SM, Woodward WA, Yu TK, Buchholz TA. Multileaf field-in-field forward-planned intensity-modulated dose compensation for whole-breast irradiation is associated with reduced contralateral breast dose: a phantom model comparison. Radiother Oncol 82(3):324-8, 3/2007. e-Pub 12/8/2006. PMID: 17157944.
25. Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TA. Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys 67(2):490-6, 2/1/2007. PMID: 17236970.
26. Garden AS, Morrison WH, Wong PF, Tung SS, Rosenthal DI, Dong L, Mason B, Perkins GH, Ang KK. Disease-control rates following intensity-modulated radiation therapy for small primary oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 67(2):438-44, 2/2007. PMID: 17141972.
27. Woodward WA, Buchholz TA, Strom EA, Perkins GH, Middleton L, Hortobagyi GN, McNeese MD, Huang EH, Tucker SL, Hahn KM. African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy. Cancer 107(11):2662-68, 12/2006.
28. Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, domain D, Buchholz TA. Local-regional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and local-regional therapy. J Clin Oncol 24(31):4971-75, 11/2006.
29. Yom SS, Morrison WH, Ang KK, Rosenthal DI, Perkins GH, Wong PF, Garden AS. Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66:469-76, 10/2006. PMID: 16887292.
30. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi GN, Theriault RL. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107:1219-26, 9/2006. PMID: 16894524.
31. Huang EH, Strom EA, Perkins GH, Oh JL, chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys 66(2):352-57, 2006.
32. Buchholz TA, Strom EA, Oswald MJ, Perkins GH, Oh JL, Domain D, Yu TK, Woodward WA, Tereffe W, Singletary SE, Thomas E, buzdar AU, Hortobagyi GN, McNeese MD. Fifteen-year results of a randomized prospective trial comparing hyperfractionated chest wall radiation versus once-daily chest wall radiation after chemotherapy and mastectomy for patients with locally advanced non-inflammatory breast cancer. Int J Radiat Oncol Biol Phys 65(4):1155-60, 2006.
33. Oh JL, Bonnen M, Outlaw ED, Schechter NR, Perkins GH, Strom EA, Babiera G, Oswald MJ, Allen PK, Thames HD, Buchholz TA. The impact of young age on locoregional recurrence after Doxorubicin-based breast conservation therapy in patients 40 years old or younger. How young is "young?". Int J Radiat Oncol biol Phys 65(5):1345-52, 2006.
34. Yom SS, Morrison WH, Ang KK, Rosenthal DI, Perkins GH, Wong PF, Garden AS. Two-field versus three-field irradiation technique in the postoperative treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys 66(2):469-76, 2006.
35. Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN. Adjuvant systemic therapy for male breast carcinoma. Cancer 104(11):2359-64, 12/2005. PMID: 16270318.
36. Strom EA, Woodward WA, Katz A, Buchholz TA, Perkins GH, Jhingran A, Theriault R, Singletary E, Sahin A, McNeese MD. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63(5):1508-13, 12/2005. PMID: 16169678.
37. Schechter NR, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN, Kronowitz SJ, Meric-Bernstam F, Babiera G, Hunt KK, Hortobagyi GN, Buchholz TA. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol 28(5):485-94, 10/2005. PMID: 16199989.
38. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62(2):351-7, 6/2005. PMID: 15890574.
39. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Babiera G, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy. Cancer 103(4):689-95, 2/2005. PMID: 15641036.
40. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22(23):4691-9, 12/2004. PMID: 15570071.
41. Yu TK, Whitman GJ, Thames HD, Buzdar AU, Strom EA, Perkins GH, Schechter NR, McNeese MD, Kau SW, Thomas ES, Hortobagyi GN, Buchholz TA. Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients. J Natl Cancer Inst 96(22):1676-81, 11/2004. PMID: 15547180.
42. Gonzalez-Angulo AM, Walters RS, Carpenter RJ, Jr, Ross MI, Perkins GH, Gwyn K, Theriault RL. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer 5(4):317-9, 10/2004. PMID: 15507181.
43. Buchholz TA, Huang EH, Berry D, Pusztai L, Strom EA, McNeese MD, Perkins GH, Schechter NR, Kuerer HM, Buzdar AU, Valero V, Hunt KK, Hortobagyi GN, Sahin AA. Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 59(5):1337-42, 8/2004. PMID: 15275718.
44. Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys 59(4):1074-9, 7/2004. PMID: 15234041.
45. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22(12):2303-12, 6/2004. PMID: 15197191.
46. Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TA. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59(1):138-45, 5/2004. PMID: 15093909.
47. Frank SJ, McNeese MD, Strom EA, Perkins G, Salehpour M, Schechter N, Buchholz TA. Advances in radiation treatments of breast cancer. Clin Breast Cancer 4(6):401-6, 2/2004. PMID: 15023240.
48. Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 100(3):490-8, 2/2004. PMID: 14745864.
49. Giordano SH, Perkins GH, Buzdar AU, Hortobagyi GN. Breast Cancer in Men: A Population-Based Study. Cancer 101(1):51-57, 2004.
50. Woodward WA, Strom EA, McNeese MD, Perkins GH, Outlaw EL, Hortobagyi GN, Buzdar AU, Buchholz TA. Cardiovascular death and second non-breast cancer malignancy after postmastectomy radiation and doxorubicin-based chemotherapy. Int J Radiat Oncol Biol Phys 57(2):327-35, 10/2003. PMID: 12957242.
51. Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57(2):336-44, 10/2003. PMID: 12957243.
52. Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TA. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21(17):3244-8, 9/2003. PMID: 12947058.
53. Perkins GH Middleton LP. Breast cancer in men. Bmj 327(7409):239-40, 8/2003. PMID: 12896911.
54. Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH. Gliomatosis cerebri: improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys 56(4):1137-46, 7/2003. PMID: 12829152.
55. Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4):926-33, 2/2003. PMID: 12569592.
56. Middleton LP, Chen V, Perkins GH, Pinn V, Page D. Histopathology of breast cancer among African-American women. Cancer 97(1 Suppl):253-7, 2003. PMID: 12491489.
57. Meric F, Mirza N, Vlastos G, Buchholz T, Kuerer H, Babiera G, Singletary S, Ross M, Ames F, Feig B, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt K. Impact of Positive Surgical Margins and Ipsilateral Breast Tumor Recurrence Predict Disease-Specific Survival after Breast-Conserving Therapy. The American Journal of Oncology Review 2(8):428-433, 2003.
58. Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera G, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese M, Strom E, Valero V, Hunt KK:. Local control determines systemic recurrence and disease-specific survival after breast-conserving therapy. Cancer 97:926-33, 2003.
59. Huang E, McNeese MD, Strom EA, Perkins GH, Katz A, Hortobagyi GN, Valero V, Kuerer HM, Singletary SE, Hunt KK, Buzdar AU, Buchholz TA. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys 53(5):1225-33, 8/2002. PMID: 12128124.
60. Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KK. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9(6):543-9, 7/2002. PMID: 12095969.
61. Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53(4):880-8, 7/2002. PMID: 12095553.
62. Buchholz T, Strom EA, Perkins GH, McNeese MD. Controversies Regarding the Use of Radiation After Mastectomy in Breast Cancer. Oncologist 7:539-46, 2002.
63. Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL:. Pathological factors that predict for local-regional recurrences after mastectomy are different for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int. J Rad Oncol Biol Phys 53:880-8, 2002.
64. Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, Frye D, Strom EA, McNeese MD, Perkins G, Katz A, Singletary SE, Hunt KK, Buzdar AU, Hortobagyi GN. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20(1):17-23, 2002. PMID: 11773149.
65. Perkins GH, McNeese MD, Antolak JA, Buchholz TA, Strom EA, Hogstrom KR. A custom three-dimensional electron bolus technique for optimization of postmastectomy irradiation. Int J Radiat Oncol Biol Phys 51:1142-51, 11/2001. PMID: 11704339.
66. Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA, McNeese MD, Perkins GH, Hunt KK. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51:671-8, 11/2001. PMID: 11597808.

Last updated: 3/5/2010